Journal
SMALL
Volume -, Issue -, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.202309215
Keywords
cancer cell stemness; chemoresistance; copper-based nanoplatform; cuproptosis; ellagic acid
Ask authors/readers for more resources
This study developed a novel nanoplatform for overcoming cancer chemotherapy resistance by using ellagic acid and copper coordination to effectively inhibit cancer cell stemness and enhance the efficacy of chemotherapy.
Drug resistance is one of the leading causes of treatment failure in current cancer chemotherapy. In addition to the classical drug efflux transporter-mediated chemoresistance, cancer cells with stemness features play a crucial role in escaping the maximum impact of chemotherapy. To sensitize cancer chemotherapy, in a novel approach, the hedgehog pathway inhibitor ellagic acid (EA) is coordinated with Cu2+ to develop nanoscale metal-organic frameworks (EA-Cu), which are then loaded with doxorubicin (DOX) and modified with targeted chondroitin sulfate (CS) to form the CS/E-C@DOX nanoplatform (CS/NPs). Notably, EA inhibits stemness maintenance by suppressing the hedgehog pathway, while Cu2+ further decreases stemness features of tumor cells by disrupting mitochondrial metabolism, effectively enhancing DOX-mediated chemotherapy. Meanwhile, EA can act synergistically with Cu2+ to cause mitochondrial dysfunction and cuproptosis, which effectively decreases ATP levels and subsequently suppresses the activity of P-glycoprotein (P-gp), thus reducing drug efflux and sensitizing DOX-mediated chemotherapy. Additionally, the attached CS endows CS/NPs with specific tumor targeting properties, whereas EA-Cu endows this nanoplatform with pH/glutathione (GSH) dual-responsive release behavior. Taken together, CS/NPs exhibited excellent antitumor effects by inducing cuproptosis and significantly inhibiting cancer cell stemness, which has great potential for overcoming cancer chemoresistance. An ellagic acid coordinated copper-based nanoplatform (CS/(E-C)@DOX NPs) capable of efficiently overcoming breast cancer chemotherapy resistance by activated cuproptosis and synergistic inhibition of cancer cell stemness. A) Schematic illustration of the preparation of CS/(E-C)@DOX NPs. B) Schematic illustration of the underlying mechanism of CS/(E-C)@DOX NPs for effectively reversing breast cancer chemotherapy resistance.image
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available